Skip to content

Participation and Environment Measure-Plus (PEM-Plus) Care Planning Intervention

Feasibility Test of a Pediatric Web-Based Care Planning Guide

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03820011
Acronym
PEM-Plus
Enrollment
28
Registered
2019-01-29
Start date
2016-07-01
Completion date
2020-08-01
Last updated
2024-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental Disability, Early Intervention (Education)

Keywords

participation, environment, goal setting

Brief summary

The goal of the proposed research is to achieve a major advance in promoting effective and efficient delivery of pediatric rehabilitation services for young children with developmental disabilities and delays. The investigative team will examine the usability, feasibility, acceptability, and preliminary effects of PEM+, an innovative web-based (mobile friendly) guide for care planning by parents of young children with developmental disabilities and delays. PEM+ is designed in partnership with parents and providers to support more collaborative and efficient clinical care planning with individual families who typically access pediatric occupational therapy services. Specifically, PEM+ enables parents to build on their baseline assessment of their child using the Young Children's Participation and Environment Measure (YC-PEM) to design specific solutions to their young child's participation-related problems. PEM+ affords parents the opportunity to do this in their own space and on their own schedule, as well as electronically share their proposed written solutions with their child's provider(s) and/or other important individuals in their young child's life.

Detailed description

Participation and Environment Measure Plus (PEM+) is a new electronic health application that facilitates family-centered and participation-focused intervention planning for young children receiving rehabilitation therapies. PEM+ design was informed by caregiver and provider input. It is a web-based intervention planning application that is designed for use by caregivers of young children receiving rehabilitation therapies. Caregivers who complete the Young Children's Participation and Environment Measure (YC-PEM), an electronic patient-reported outcome measure, evaluate their child's participation and then can click on a weblink to begin the PEM+ application, whereby they build on their YC-PEM responses for the purpose of creating a participation-focused care plan to share with their child's rehabilitation team. PEM+ is a five-step recursive process (i.e., the caregiver can repeat the five-step process to create as many care plans for their child as needed), and it offers tiered support to the user during completion (tier 1: frequently asked questions available in the application, tier 2: support provided by email, tier 3: support provided by phone). For the first aim of this study, caregivers completed one iteration of PEM+ to complete user tasks for the purpose of evaluating PEM+ usability. For the second aim of this study, caregivers were instructed to complete the PEM+ over a two-week (14 day) period. This time frame was selected by the research team as it mimics what would be provided in the routine care planning processes of early intervention and early childhood education.

Interventions

OTHERPEM+

PEM+ is a five-step recursive process (i.e., the caregiver can repeat the five-step process to create as many intervention plans for their child as needed, relative to the number of activities in which change is desired based on the YC-PEM e-PRO, and it offers tiered support to the user during completion (tier 1: frequently asked questions available in the application, tier 2: support provided by email, tier 3: support provided by phone).

Sponsors

McGill University
CollaboratorOTHER
McMaster University
CollaboratorOTHER
Mary A Khetani
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Aim 1 Inclusion Criteria: * at least 18 years old * reads, writes, and speaks English * has access to broadband internet * resides in the U.S * has a child between 0 and 3 years old who is receiving services for developmental delay. Aim 1

Exclusion criteria

* has a child over 3 years old * does not have internet access * has a child who is not receiving rehabilitation services for developmental delay * does not reside in the U.S. Aim 2 Inclusion Criteria: * 18 years or older * reads, writes, and speaks in English * has a child aged 0-5 years old who was receiving rehabilitation services * has broadband internet access * denotes at least one area of desired change during participation assessment. Aim 2

Design outcomes

Primary

MeasureTime frameDescription
Mean Retention RatesFollowing completion of two-week trialAs an indicator of PEM+ feasibility, we used web analytics to obtain estimates of the percentage of caregivers who enrolled completed the trial.
Median PEM+ Completion TimeFollowing completion of PEM+ iteration (Aim 1) and two weeks (Aim 2)As an indicator of PEM+ feasibility, we used web analytics to estimate the median time for completing the first and subsequent iterations within a two-week trial period
Percentage of Caregivers Completing PEM+ IndependentlyFollowing completion of two-week trialAs an indicator of PEM+ feasibility, we used web analytics to estimate proportion of care plans created
Median Number of PEM+ Care Plans CreatedFollowing completion of two-week trialAs an indicator of PEM+ feasibility, we used web analytics estimate the number of care plans created over a two-week trial period.
Usefulness, Satisfaction, and Ease of Use Questionnaire (USE)Following completion of two-week trialAs an indicator of PEM+ acceptability, the USE is a questionnaire that evaluates usefulness, ease of use, ease of learning, and satisfaction. Items are on a 7-point scale, from from \[1\] strongly disagree, to \[7\] strongly agree. There were multiple items for each domain, which were summed together and divided by the total number of items to generate a summary score for that domain. Higher scores indicate a better outcome.
Caregiver Self-Efficacy to Promote Child's Participation in ActivitiesFollowing completion of two-week trialAs an indicator of preliminary effects, we developed two items for this project to estimate caregiver self-efficacy in caring for their child, according to what I will do next \[to support child's participation\] and how I think \[about my child's participation\]. Each item was rated on a 7-point scale, from \[1\] strongly disagree, to \[7\] strongly agree. Higher scores indicate a better outcome.

Participant flow

Participants by arm

ArmCount
PEM-Plus Group (Aim 2)
For Aim 2, caregivers who completed the YC-PEM e-PRO clicked on a weblink to begin PEM+, whereby they built on their YC-PEM responses to create care plans to share with their child's rehabilitation team. Caregivers were instructed to complete the PEM+ over a 14-day period because it mimics routine care. PEM+ is a five-step recursive process (i.e., the caregiver repeats the process to create as many intervention plans for their child as needed), and it offers tiered support to the user during completion (tier 1: frequently asked questions available in the application, tier 2: support provided by email, tier 3: support provided by phone).
22
PEM-Plus Group (Aim 1)
For Aim 1, 6 parents of young children were recruited to perform tasks related to navigating the PEM+ interface. Data on completion rate and time and user satisfaction were analyzed to guide PEM+ improvements.
6
Total28

Baseline characteristics

CharacteristicTotalPEM-Plus Group (Aim 2)PEM-Plus Group (Aim 1)
Age, Categorical
Age of caregiver
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
Age of caregiver
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Age of caregiver
Between 18 and 65 years
28 Participants22 Participants6 Participants
Race/Ethnicity, Customized
Asian
4 Participants3 Participants1 Participants
Race/Ethnicity, Customized
Black or African American
2 Participants2 Participants0 Participants
Race/Ethnicity, Customized
Other or Not Disclosed
5 Participants3 Participants2 Participants
Race/Ethnicity, Customized
White
17 Participants14 Participants3 Participants
Sex: Female, Male
Female
26 Participants20 Participants6 Participants
Sex: Female, Male
Male
2 Participants2 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 28
other
Total, other adverse events
0 / 28
serious
Total, serious adverse events
0 / 28

Outcome results

Primary

Caregiver Self-Efficacy to Promote Child's Participation in Activities

As an indicator of preliminary effects, we developed two items for this project to estimate caregiver self-efficacy in caring for their child, according to what I will do next \[to support child's participation\] and how I think \[about my child's participation\]. Each item was rated on a 7-point scale, from \[1\] strongly disagree, to \[7\] strongly agree. Higher scores indicate a better outcome.

Time frame: Following completion of two-week trial

Population: This Outcome Measure was pre-specified to be only assessed under Aim 2 of the study, to identify clinical outcomes to include in a future efficacy trial of the PEM+ intervention.

ArmMeasureGroupValue (MEAN)Dispersion
PEM-Plus Group (Aim 2)Caregiver Self-Efficacy to Promote Child's Participation in ActivitiesPEM+ influenced what I think can be done4.72 score on a scaleStandard Deviation 2.24
PEM-Plus Group (Aim 2)Caregiver Self-Efficacy to Promote Child's Participation in ActivitiesPEM+ influenced what I will do4.61 score on a scaleStandard Deviation 1.85
Primary

Mean Retention Rates

As an indicator of PEM+ feasibility, we used web analytics to obtain estimates of the percentage of caregivers who enrolled completed the trial.

Time frame: Following completion of two-week trial

Population: As stated in our published article, a total of 22 of the 27 participants recruited confirmed their eligibility, and 18 of the 22 participants who confirmed study eligibility continued with PEM+ use. This outcome is specific to Aim 2.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PEM-Plus Group (Aim 2)Mean Retention Rates18 Participants
Primary

Median Number of PEM+ Care Plans Created

As an indicator of PEM+ feasibility, we used web analytics estimate the number of care plans created over a two-week trial period.

Time frame: Following completion of two-week trial

Population: This Outcome Measure was pre-specified to be only assessed under Aim 2 of the study. Aim 1 only required caregivers to complete a single iteration of PEM+, so all participants completed it one time. Aim 2 required caregivers to complete as many iterations of PEM+ as possible over 2 weeks, so participants could complete PEM+ one or more times.

ArmMeasureValue (MEDIAN)
PEM-Plus Group (Aim 2)Median Number of PEM+ Care Plans Created2.5 care plans
Primary

Median PEM+ Completion Time

As an indicator of PEM+ feasibility, we used web analytics to estimate the median time for completing the first and subsequent iterations within a two-week trial period

Time frame: Following completion of PEM+ iteration (Aim 1) and two weeks (Aim 2)

ArmMeasureValue (MEDIAN)
PEM-Plus Group (Aim 2)Median PEM+ Completion Time13.6 minutes
PEM-Plus Group (Aim 2)Median PEM+ Completion Time12.99 minutes
Primary

Percentage of Caregivers Completing PEM+ Independently

As an indicator of PEM+ feasibility, we used web analytics to estimate proportion of care plans created

Time frame: Following completion of two-week trial

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PEM-Plus Group (Aim 2)Percentage of Caregivers Completing PEM+ Independently17 Participants
Primary

Usefulness, Satisfaction, and Ease of Use Questionnaire (USE)

As an indicator of PEM+ acceptability, the USE is a questionnaire that evaluates usefulness, ease of use, ease of learning, and satisfaction. Items are on a 7-point scale, from from \[1\] strongly disagree, to \[7\] strongly agree. There were multiple items for each domain, which were summed together and divided by the total number of items to generate a summary score for that domain. Higher scores indicate a better outcome.

Time frame: Following completion of two-week trial

ArmMeasureGroupValue (MEAN)Dispersion
PEM-Plus Group (Aim 2)Usefulness, Satisfaction, and Ease of Use Questionnaire (USE)Ease of Learning4.97 score on a scaleStandard Deviation 1.57
PEM-Plus Group (Aim 2)Usefulness, Satisfaction, and Ease of Use Questionnaire (USE)Usefulness4.41 score on a scaleStandard Deviation 1.54
PEM-Plus Group (Aim 2)Usefulness, Satisfaction, and Ease of Use Questionnaire (USE)Satisfaction3.80 score on a scaleStandard Deviation 1.97
PEM-Plus Group (Aim 2)Usefulness, Satisfaction, and Ease of Use Questionnaire (USE)Ease of Use4.64 score on a scaleStandard Deviation 1.25
PEM-Plus Group (Aim 2)Usefulness, Satisfaction, and Ease of Use Questionnaire (USE)Satisfaction4.2 score on a scaleStandard Deviation 5.7
PEM-Plus Group (Aim 2)Usefulness, Satisfaction, and Ease of Use Questionnaire (USE)UsefulnessNA score on a scale
PEM-Plus Group (Aim 2)Usefulness, Satisfaction, and Ease of Use Questionnaire (USE)Ease of Learning5.4 score on a scaleStandard Deviation 6
PEM-Plus Group (Aim 2)Usefulness, Satisfaction, and Ease of Use Questionnaire (USE)Ease of Use4.4 score on a scaleStandard Deviation 5.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026